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Purpose: To compare surgical outcomes of robotic radical hysterectomy (RRH) us-
ing 3 robotic arms with those of conventional laparoscopy in patients with early cer-
vical cancer. Materials and Methods: A retrospective cohort study included 102 pa-
tients with stage 1A1-IIA2 cervical carcinoma, of whom 60 underwent robotic and 
42 underwent laparoscopic radical hysterectomy (LRH) with pelvic lymph node dis-
section performed between December 2009 and May 2013. Perioperative outcomes 
were compared between two surgical groups. Results: Robotic approach consisted 
of 3 robotic arms including the camera arm and 1 conventional assistant port. Lapa-
roscopic approach consisted of four trocar insertions with conventional instruments. 
There were no conversions to laparotomy. Mean age, body mass index, tumor size, 
cell type, and clinical stage were not significantly different between two cohorts. 
RRH showed favorable outcomes over LRH in terms of estimated blood loss (100 
mL vs. 145 mL, p=0.037), early postoperative complication rates (16.7% vs. 30.9%, 
p=0.028), and postoperative complications necessitating intervention by Clavien-
Dindo classification. Total operative time (200.5±61.1 minutes vs. 215.6±83.1 min-
utes, p=0.319), mean number of lymph node yield (23.3±9.3 vs. 21.7±9.8, p=0.248), 
and median length of postoperative hospital stay (11 days vs. 10 days, p=0.129) were 
comparable between robotic and laparoscopic group, respectively. The median fol-
low-up time was 44 months with 2 recurrences in the robotic and 3 in the laparo-
scopic cohort. Conclusion: Surgical outcomes of RRH and pelvic lymphadenecto-
my were comparable to that of laparoscopic approach, with significantly less blood 
loss and early postoperative complications.
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INTRODUCTION
Laparoscopic surgery has been known to have advantages over laparotomy, in-
cluding reduced pain, improved aesthetics, shorter length of hospital stay, and fast-
er return to normal activities.1,2 These benefits of laparoscopy have driven efforts 
to achieve further development in minimally invasive surgical technology, one of 
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at Yonsei University College of Medicine. After excluding 
hysterectomy for benign conditions, endometrial cancer stag-
ing, and fertility sparing trachelectomy, a total of 102 patients 
who received radical hysterectomy with pelvic lymph node 
dissection±paraaortic lymph node sampling performed be-
tween December 2009 and May 2013 were identified. In-
clusion criteria were women with newly diagnosed untreated 
invasive cervical cancer, International Federation of Gyne-
cology and Obstetrics (FIGO) stage IIA2 or less disease 
with Gynecologic Oncologic Group performance score ≤1. 
Another specific inclusion criteria for robotic surgery was 
the financial capability to pay the surgical cost ($10000). 
Exclusion criteria for performing laparoscopic surgery were 
patients with uterine size greater than 16 gestational weeks 
by pelvic examination and those with previous history of 3 
or more open abdominal surgeries. All procedures were 
performed by surgeons experienced and proficient in ad-
vanced laparoscopic gynecologic procedures. The surgical 
team consisted of a chief resident or fellow as surgical as-
sistants at the bedside or at the caudal part of the patient for 
uterine manipulation.
Data pertaining to patient characteristics (age, parity, 
body mass index, and general health status) and periopera-
tive parameters including docking time (DT), console time 
(CT), total operative time (OT), estimated blood loss, num-
ber of retrieved lymph nodes, pathologic analysis, length of 
hospital stay, and perioperative complications were retro-
spectively reviewed from the prospectively entered com-
puterized database. The total OT was the time from the first 
skin incision to the last port site skin closure. Number of 
lymph node retrieval was the number of pelvic lymph nodes 
identified at pathologic analysis. Complications were cate-
gorized as intraoperative and postoperative (early/late) 
events. Clavien-Dindo classification was used to stratify 
complications into five grades according to their therapeu-
tic interventions.18
Surgical techniques
After general anesthesia, the patient was placed in a low 
dorsal lithotomy and steep Trendelenburg position. A nela-
ton catheter was inserted to drain the bladder. RUMI uter-
ine manipulator with a Koh colpotomy ring and vaginal 
balloon pneumo-occluder (Cooper Surgical Inc., Trumball, 
CT, USA) was routinely placed for adequate pelvic expo-
sure. Ports were placed after creating pneumoperitoneum 
by Veress needle insertion or by open Hasson method at the 
umbilicus. The surgical management of cervical cancer in-
which is the incorporation of robotic assistance. Since Food 
and Drug Administration approval for the use of the da Vin-
ci Surgical System (Intuitive Surgical Inc., Sunnyvale, CA, 
USA) in gynecologic procedures in 2005, many studies 
have demonstrated the advantages of robotic assistance in 
overcoming the drawbacks of conventional laparoscopy.3-5 
These advantages include a magnified three-dimensional 
view, wider range of motion with wristed instruments, and 
improved surgeon ergonomics with surgical stability.6,7 
Therefore, when a surgeon performs an extensive gyneco-
logic oncology procedure such as radical hysterectomy 
with lymph node dissection, the robotic assistance is theo-
retically expected to help accomplish complex tasks such 
as deep pelvic space dissection, adhesiolysis, ureterolysis, 
and multiple suturing with ease, compared to conventional 
straight stick laparoscopy. 
For early stage cervical cancer treatment, adequate radi-
cal hysterectomy followed by tailored adjuvant therapy is 
of paramount importance for prognosis.8,9 Conventional 
laparoscopic radical hysterectomy (LRH) for these patients 
has come to be regarded as a reasonable alternative to open 
surgical method, and more recently, the application of robot-
ic technology has shown to be feasible and safe as well.10-15 
However, there is still a lack of studies addressing the surgi-
cal and oncologic outcomes of these two minimally inva-
sive methods, since robot-assisted radical hysterectomy 
(RLH) is a relatively novel surgical technique that has not 
yet been studied in a randomized controlled trial setting.16 
Also, in countries where high cost is one of the biggest con-
cerns in adopting robotic surgery, there may be different sur-
gical outcomes due to modification of surgical practice such 
as applying strict eligibility criteria for robotic approach or 
reducing the number of robotic arms.17
Nonetheless, minimally invasive surgical approach may 
provide benefit for patients with gynecological malignancies 
because of earlier postoperative interventions such as adju-
vant chemotherapy or radiation due to less complications 
and a faster recovery. Therefore, the purpose of this study 
was to compare the surgical outcomes of robotic radical 
hysterectomy (RRH) using only 3 robotic arms with those 
of conventional four-port laparoscopic radical hysterecto-
my (LRH) in patients with early cervical cancer.
MATERIALS AND METHODS
The study was approved by the Institutional Review Board 
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arms securely to the port sites. The CT was defined as the 
time spent by the surgeon at the robotic console during the 
main procedure. The vaginal cuff was closed intracorpore-
ally using interrupted or continous sutures of 1-Vicryl (Eth-
icon, Piscataway, NJ, USA) or extracorporeally using a 
Clarke-Reich knot pusher. Upon completion of the proce-
dure, the fascia of the port sites greater than 8 mm in diam-
eter were closed with interrupted suture using 1-0 Vicryl 
(Ethicon, Piscataway, NJ, USA). 
Laparoscopic approach
For conventional LRH, a 5-mm trocar was inserted as the 
camera port through a vertical incision made inside the um-
bilicus. A 30 cm length 30-degree endoscope with 5 mm in 
diameter was used. The surgeon was at the left side of the 
patient using the two 5 mm ports on the left side. A 5 or 11 
mm trocar was placed in the right lower quadrant for the 
first assistant (Fig. 1B). For both laparoscopic and robotic 
procedures, Lap bag (Sejong Medical, Paju, Korea) for in-
traperitoneal lymph node storage during lymphadenectomy 
was introduced if necessary. Since there were bulky lymph 
nodes that needed to be extracted safely without spillage into 
the trocar or in the peritoneal cavity, this method was used 
rather than retrieving each lymph nodes through the assistant 
trocar. Gathered lymph nodes were removed transvaginally 
altogether after the completion of hysterectomy. Conven-
tional instruments such as monopolar hook and bipolar 
graspers were used. Energy devices such as Harmonic Ace 
(Ethicon Endo-surgery, Cincinnati, OH, USA) or LigaSure 
system (Valleylab Inc., Boulder, CO, USA) were used ac-
cording to surgeon’s preference. For vaginal cuff closure, a 
1-0 Vicryl with a 40-mm round-bodied needle was intro-
duced through the 11-mm port and closed intracorporeally 
in a continuous running suture method. The fascia of the an-
cluded radical hysterectomy with removal of bilateral pelvic 
lymph nodes as described in our previous report.19 The de-
cision to perform paraaortic lymph node dissection was at 
the surgeon’s discretion, up to the level of inframesenteric 
artery. Modified radical or radical hysterectomy was per-
formed according to disease extent. Nerve sparing radical 
hysterectomy is not a routine practice at our institution. In 
brief, the procedure consisted of eight component parts: 1) 
development of the paravesical and pararectal spaces, 2) 
right and left pelvic lymphadenectomy from common iliac 
nodes to bilateral inguinal nodes, 3) ureteral dissection, 4) 
ligation and dissection of the uterine artery, 5) development 
of the vesicouterine and rectovaginal spaces, 6) resection of 
the parametria, 7) resection of the upper vagina, and 8) vag-
inal cuff closure. Adequacy of the component parts of this 
procedure was routinely determined and documented on 
video. 
Robotic approach
All robotic surgeries were performed using the da Vinci ro-
botic surgical system (Intuitive Surgical Inc., Sunnyvale, 
CA, USA) with Maryland Bipolar and Permanent Cautery 
Spatula or needle holder on each robotic arm. Four trocars 
with three robotic arms were used for port placement: a 12-
mm conventional laparoscopic trocar at the umbilicus for 
the camera, two 8-mm lateral robotic trocars at each lower 
quadrant of the abdomen 2 to 3 cm below the umbilical 
level, and a fourth conventional trocar (either 5 or 10 mm) 
at mid-distance between the umbilicus and the left robotic 
arm for the bedside assistant (Fig. 1A). The bedside assis-
tant assisted procedures such as suction, irrigation, retrac-
tion of tissues, and lymph node retrieval through the 5 or 10 
mm trocar placed on the left side of the patient. DT was de-
fined as the time to position the robot and install the robotic 
Fig. 1. Port placement. (A) Robotic radical hysterectomy. (B) Laparoscopic radical hysterectomy.
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weight were not significantly different between the two sur-
gical cohorts. All cases were completed through robot or 
laparoscopic approach without conversion to laparotomy. 
According to Piver classification, 12 cases (28.6%) and 30 
cases (71.4%) received type 2 and type 3 radical hysterec-
tomy, respectively, in the laparoscopic cohort. There was no 
significant difference in radicality in the robotic group as 
well, with 11 cases (18.6%) and 48 cases (81.4%) of type 2 
and 3 radical hysterectomy, respectively (p=0.336). Surgi-
cal types of radical hysterectomy were further divided ac-
cording to the Querleu and Morrow20 classification (Table 
2). Only 2 cases in each surgical cohort underwent auto-
nomic nerve sparing radical hysterectomy (type C1) since it 
is not a routine practice at our institution. There was no dif-
ference in the total OT between the two groups (200.5 and 
215.6 minutes for robotic and laparoscopic group, respec-
tively; p=0.319). The mean CT of the robotic cohort was 
152 minutes. There was no significant difference in the ac-
quired number of pelvic and para-aortic lymph nodes be-
tween the two cohorts, although a significantly less amount 
of blood loss was seen in the robotic group (median 100 
mL, range 30--600 mL, p=0.037). The case with the least 
amount of blood loss was measured in a patient with stage 
1A1 disease with lymphovascular space invasion who under-
went modified radical hysterectomy with pelvic lymph node 
dissection. Postoperative pathologic data including tumor 
size, invasion depth, and lymph node metastasis did not 
cillary port site on the right lower quadrant was approximat-
ed with 1-0 Vicryl only when a 11-mm trocar was inserted. 
All wounds of laparoscopic incision sites equal or less than 
5 mm were closed only with Steri-StripsTM (3M, St. Paul, 
MN, USA). 
Statistical analysis was performed with IBM SPSS ver-
sion 20 for Windows (SPSS Inc., Chicago, IL, USA), and 
Kolmogorov Smirnov test was used to verify standard nor-
mal distributional assumptions. Student’s t-test and Mann-
Whitney U test were used for parametric and non-paramet-
ric variables, respectively. Differences between proportions 
were compared using Fisher’s test or χ2 test. A p value of 
less than 0.05 was regarded as statistically significant. Sur-
vival outcome was estimated using the Kaplan-Meier meth-
od and groups were compared by log-rank test.
 
RESULTS
 
One hundred two consecutive radical hysterectomy proce-
dures performed by robotic or conventional laparoscopic 
approach were identified during the study period. Patient 
characteristics are shown in Table 1. The mean age was less 
than 50 years, and most of the patients (75/102, 73.5%) had 
clinical FIGO stage 1B1 disease with predominantly squa-
mous cell carcinoma. Other histology included adenosqua-
mous and small cell types. Body mass index and uterine 
Table 1. Overall Patient Characteristics (n=102)
Parameter Robotic group (n=60)
Conventional laparoscopic 
group (n=42)
p value
Mean age, yrs (SD) 46.3 (9.9)   49.8 (11.4) 0.096*
Median BMI, kg/m2 (range) 22.5 (18.2--38.6)   22.7 (15.8--33.3) 0.992†
Number of previous abdominal surgery, median (range)      0 (0--2)        0 (0--1) 0.002†
Mean uterine weight, g (SD)  132 (65.4) 139.4 (70.2) 0.595*
Clinical FIGO stage, n (%)
    IA1, LVI      2 (3.3)        4 (9.5) 0.576‡
    IA2      2 (3.3)        1 (2.4)
    IB1    46 (76.7)      29 (69.0)
    IB2      4 (6.7)        1 (2.4)
    IIA1      3 (5.0)        4 (9.5)
    IIA2      4 (6.0)        3 (7.2)
Cell type, n (%) 0.080‡
    Squamous    36 (60.0)      33 (78.6)
    Adenocarcinoma    13 (21.7)        8 (19.0)
    Other    11 (18.3)        1 (2.4)
BMI, body mass index; SD, standard deviation; FIGO, International Federation of Gynecology and Obstetrics; LVI, lymphovascular space infiltration.
*Student’s t-test.
†Mann-Whitney U test. 
‡Fisher’s exact test.
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vien-Dindo classification), except one case of panperitonitis 
from bowel perforation, which developed postoperatively in 
the 59th patient of the robotic cohort that needed surgical 
correction (grade IIIB). An inadvertent surgical intervention 
needed in the conventional laparoscopic cohort was a case of 
remnant peritoneal drain catheter after an attempt for remov-
al. The patient underwent emergency laparoscopic removal 
of the catheter tip left inside the peritoneal cavity. The overall 
postoperative complications after 6 weeks were found to be 
higher in the conventional laparoscopic group with only 
marginal statistical significance (p=0.054). Also, postopera-
tive complications higher than grade 3, defined as those re-
quiring surgical or radiological intervention, occurred in 2 
patients each of robotic (3.4%) and laparoscopic (4.8%) 
group (p=0.021). 
DISCUSSION
The present results showed comparable surgical outcomes 
of RRH to that of conventional laparoscopic approach in 
the treatment of early cervical cancer, with lower intraoper-
show significant difference between the two groups. The 
mean survival time in the cohorts was 40.7 months in the ro-
botic group (2 recurrences) and 42.0 months in the laparo-
scopic group (3 recurrences), yielding a 3-year relapse-free 
survival of 96.4% and 91.9%, respectively, without statisti-
cal significance (data not known, p=0.482). One death oc-
curred in a patient with FIGO stage 1B1 disease with small 
cell type who underwent RRH with bilateral pelvic lymph 
node dissection. Although she received postoperative che-
motherapy due to high risk histologic type, pelvic recur-
rence occurred postoperative 5 months and subsequent 
death 21 months after the treatment. 
Intraoperative and postoperative complications (including 
all minor complications such as transient febrile event to ma-
jor complications including bowel injury) occurred in 13 pa-
tients (21.7%) in the robotic cohort and in 21 patients (50.0%) 
in the conventional laparoscopic group (Table 3). Early post-
operative complications (<6 weeks after surgery) were sig-
nificantly lower in the robotic group than laparoscopic group 
(16.7% vs. 30.9%, respectively, p=0.028). Most of early and 
late postoperative complications were spontaneously re-
solved by conservative management (grade 1 or 2 by Cla-
Table 2. Comparison of Perioperative Outcomes by Surgical Approach
Robotic group (n=60)
Conventional laparoscopic 
group (n=42)
p value
Procedure type (by Querleu classification) 0.190‡
    Type B1        2        5
    Type B2      10        7
    Type C1        2        2
    Type C2      46      28
Bilateral salpingo-oophorectomy, n (%)      33 (55.0)      29 (69.0) 0.343‡
Ovarian transposition, n (%)        5 (8.3)        3 (7.1) 1.000‡
Para-aortic lymphadenectomy, n (%)        5 (8.3)        8 (19.0) 0.075*
Total operative time, min (SD) 200.5 (61.1) 215.6 (83.1) 0.319*
    Docking time, min (SD)     5.2 (3.4) 
    Console time, min (SD)    152 (42.4)
Number of pelvic lymph nodes, mean (SD)      18 (8.3)   19.9 (8.1) 0.248*
Estimated blood loss, mL, median (range)    100 (30--600)    145 (50--700) 0.037†
Pathologic tumor size, mm (SD)      22 (10)      22 (8) 0.941*
Depth of invasion, mm     7.5     7.1 0.821
Lymph node metastasis, n (%)        6 (10.0)        6 (14.3) 0.545‡
Postoperative hospital stay, days, median (range)      11 (4--51)      10 (5--23) 0.129†
Postoperative adjuvant therapy, n (%)      21 (35.1)      17 (40.4) 0.611‡
Median follow up, months (range)      25 (3--42)   19.5 (3--45) 0.408†
    Number of recurrence        2         3
    Number of death        1         0
SD, standard deviation.
*Student’s t-test.
†Mann-Whitney U test.
‡Fisher’s exact test.
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minimally invasive surgery, ranging from 3.3% to 43.5%, 
as shown in a study by Hoekstra, et al.23 Likewise, the num-
ber of robotic surgery for gynecologic malignancies has 
rapidly increased from 21 to over 300 cases in 2012 at our 
institution since the implement of robotic platform in 2006. 
Despite the universal increase in robotic surgery, there have 
been only 27 studies evaluating the surgical outcomes of 
RRH until 2011 in comparison with LRH with relatively 
small number of subjects.16 A recent meta-analysis indicat-
ed that comparison of robotic and conventional laparoscop-
ic surgery was not feasible due to insufficiency in studies 
that assessed proper ‘radical’ hysterectomy solely for cervi-
cal cancer.24 This suggests a need for more comparative 
studies with consistency in the operative procedures per-
formed. In this study cohort, all cases were performed ac-
ative blood loss and early complication rates.
The clinical impact of robotic surgery in gynecologic 
field is growing widely, as suggested by a recent consensus 
statement made by the Society of Gynecologic Oncology in 
2012.21 The society has stated that the current evidence sup-
ports at least an equivalence of robotic surgery and laparos-
copy in many perioperative outcomes. However, there is a 
lack of disease specific oncologic outcomes and the cost is 
still a potential barrier to the widespread acceptance of ro-
botic surgery.19,22 The cost barrier is a problem not only in 
the U.S., but  also in Korea especially where this relatively 
new technology is not covered by the national insurance. 
Nevertheless, the number of robotic surgeries is growing 
and the implementation of robotic surgery in gynecologic 
oncology has made a dramatic change in the proportion of 
Table 3. Complications
Robotic group (n=60)
Conventional laparoscopic 
group (n=42)
p value
Overall complications, n (%) 13 (21.7) 21 (50.0) 0.023*
Intraoperative (%)   0 (0)   1 (2.3) 0.508†
    Hemorrhage requiring transfusion   0   1
Early postoperative (<6 wks), n (%) 10 (16.7) 13 (30.9) 0.028†
    Febrile morbidity   2   6
    Severe leg edema/pain   1   0
    Leg weakness   1   0
    Vaginal vault bleeding   1   0
    Vaginal vault leakage   0   2
    Vaginal vault infection   0   1
    Voiding difficulty   2   3
    Urinary tract infection   1   0
    Hematuria   1   0
    Rectovaginal fistula   0   0
    Panperitonitis due to bowel injury   1   0
    Remnant drain catheter   0   1
Late posteroperative (>6 wks), n (%)   3 (5.0)   6 (14.6) 0.054*
    Vaginal vault bleeding   0   2
    Vaginal vault dehiscence   1   1
    Vaginal vault infection   0   1
    Voiding difficulty   1   1
    Vesicovagina fistula   0   1
    Ureterovagina fistula   1   0
Clavien-Dindo classification of postoperative complications 0.021*
    I (no treatment)   8 (13.3)   8 (19.0)
    II (need for pharmacological treatment)   3 (5.0)   9 (21.4)
    IIIA (intervention under local anesthesia)   1 (1.7)   0
    IIIB (intervention under general anesthesia)   1 (1.7)   2 (4.8)
    IV (intensive care due to single or multiorgan failure)   0   0
    V (death)   0   0
*Fisher’s exact test.
†Chi-square.
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as bleeding, dehiscence, and infection after conventional 
laparoscopy. Since suture and knot tying are technically 
more difficult than that with the wristed robotic instruments, 
the vaginal vault would have been closed more firmly and 
completely through the robotic approach. However, this find-
ing is inconclusive since vaginal vault closure per surgical 
method was not uniform in the entire cohort. Further analy-
sis with a larger cohort and thorough evaluation of suture 
methods may clarify this matter. Nevertheless, the overall 
postoperative complications requiring pharmacological and 
surgical intervention (Clavien-Dindo classification grade of 
2--3B) were significantly lower in the robotic group (5/60, 
8.3%), compared with laparoscopic group (11/42, 26.2%, 
p=0.021).
The reason for using only 3 robotic arms for all robotic 
gynecologic surgery at our institution is directly linked to 
cost issues. High cost is the major obstacle for deciding ro-
botic surgical approach and also for launching a random-
ized clinical study. The patient expense for robotic cancer 
surgery is approximately 4 times higher than the conven-
tional laparoscopic surgery, since the robotic surgical cost is 
not reimbursed by the National health insurance. Therefore, 
by eliminating one robotic arm, the patient can save ap-
proximately US $500. So far, we have performed success-
ful robotic surgeries with only 3 robotic arms without major 
technical difficulties. The function of a 4th arm had been 
performed by the bedside assistant, and we believe that this 
is also important for training purposes, since robotic sur-
gery provides a unique challenge with regard to resident 
training because of remote location from the surgeon con-
sole.25 Three-arm usage is a unique characteristic, unlike 
many other studies on robotic gynecologic surgery that use 
mostly four robotic arms for radical hysterectomy.16,26,27 An-
other factor that is affected by the overall cost is the length 
of hospital stay. The number of days was not comparable 
between the two surgical methods because of routine post-
operative bladder catheter training prior removal and also 
the patients’ preference to remain hospitalized for a pro-
longed period of time despite a minimally invasive surgery. 
The biggest reason is the very low hospital admission fee 
due to comprehensive national insurance coverage in Korea.
Oncologic outcome and survival are important factors to 
analyze when implementing a novel surgical approach. Al-
though the survival data were not analyzed in detail in this 
study, Kaplan-Meier survival analysis demonstrated 96.4% 
recurrence-free survival (RFS) at 40.7 months due to the re-
currence of 2 patients in the RRH cohort and 91.9% RFS at 
cording to Piver classification of modified radical or radical 
hysterectomy by clinical stage, and further reclassified ret-
rospectively according to the new Querleu and Morrow 
classification to clarify whether or not nerve preservation 
and paracervical nodal removal were performed. Also, this 
study is one of the few reports that included fairly a large 
number of patients in the robotic cohort consisting of only 
radical hysterectomy. 
The findings of this study are comparable with a recent 
review by Kruijdenberg, et al.,16 which compared surgical 
outcomes of 11 studies (342 patients) of RRH versus 18 
studies (914 patients) of LRH. There was no difference in 
OT and lymph node yields between robotic and laparoscop-
ic approach, however, significantly shorter hospital stay was 
found after RRH, similar to the results of our study. In our 
series, the intraoperative blood loss and complications rates 
were significantly lower in the robotic cohort as well. Inter-
estingly, Kruijdenberg, et al.16 showed that although the to-
tal percentage of major intraoperative complications was 
comparable in both methods, the ‘type’ of complications dif-
fered according to the treatment method. Despite the small 
patient population in the RRH publications, more nerve in-
jury was observed during robotic surgery whereas higher 
vascular and bladder injury was seen during conventional 
laparoscopic surgeries. The authors suggested that these 
findings are associated with improved visualization and 
ability to coagulate fast, and dissect more precisely with the 
robotic instruments due to filtered tremor and enhanced ap-
proachability to the surgical field. As for the nerve injury, 
they speculated possible thermal energy damage produced 
by predominantly monopolar and bipolar robotic cautery. 
Likewise, there seemed to be a trend in the complications 
in our series as well. Although the overall complication rate 
was statistically lower in the RRH cohort, the incidence of 
severe leg edema and leg weakness was more frequent in 
the RRH group. Our hypothesis is that enhanced visualiza-
tion and ergonomics might have provided the ease for ex-
tensive pelvic space dissection, which led to more profound 
leg lymph edema due to increased lymph node dissection. 
However, it is difficult to support this finding with the num-
ber of lymph node yields obtained in this study, since the 
lymph node counting method is not standardized at our in-
stitution. This is one of the limitations of our data, that the 
number of lymph nodes in a bulky pelvic lymphatic tissue 
was not entirely counted, according to the protocol of the 
pathologic department. Another interesting finding is the 
higher number of vaginal vault-related complications such 
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In conclusion, surgical outcomes of RRH and pelvic 
lymphadenectomy were comparable to that of laparoscopic 
approach, with favorable outcomes in regards to intraopera-
tive blood loss and postoperative complications. Further 
studies on long term surgical outcome and survival are 
needed to confirm potential oncologic benefits of RRH 
compared with conventional laparoscopic treatment.
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